Skip to main content

Table 5 The long term morbidity of the following are not well characterised

From: Treatment related morbidity in differentiated thyroid cancer–a survey of clinicians

Complication (number of responders)

Strongly agree

Disagree

Neutral/don’t know

Agree

Strongly agree

Hypocalcaemia (118)

7 (5.9%)

32 (27.1%)

14 (11.9%)

59 (50.0%)

6 (5.1%)

Significant voice change (117)

12 (10.3%)

34 (29.1%)

12 (10.3%)

54 (46.2%)

5 (4.3%)

TSH suppression (116)

6 (5.2%)

19 (16.4%)

24 (20.7%)

57 (49.1%)

10 (8.6%)

  1. NA, not applicable; CVS, cardiovascular; TSH, thyroid stimulating hormone.